Immuno Oncology Assays Market: In-Depth Analysis of Growing Demand, Major Market Dynamics and Their Impact

 


Immuno-Oncology Assays: Market Overview:

The growth of this market is primarily driven by factors such as the increasing adoption of targeted therapy over traditional therapy and increasing demand for mAbs. However, the high cost of immunotherapy treatment and the high attrition rate in the product development cycle are the major factors that are expected to restrain the growth of this market during the forecast period.

The market for immuno-oncology assays is expected to reach USD 5.9 billion by 2024 from USD 2.9 billion in 2018, at a CAGR of 12.7%.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=52562166

In-Depth Market Segmentation:

Products:

Based on products, the immuno-oncology assays market is segmented into consumables and software. The consumables segment dominated the market with the largest share in 2018; this segment is also expected to register the highest CAGR during the forecast period. The large share of this segment can be attributed to the availability of a wide range of reagents and kits, increasing use of reagents in different oncology therapeutic treatments, increasing research on cancer immunotherapy.

Application:

Based on application, the immuno-oncology assays market is segmented into research applications and clinical diagnostics. Research applications dominated the market with the largest share in 2018. It is also projected to be the fastest-growing segment during the forecast period. The rising prominence of biomarker-based drug development and clinical trials and the emergence of cancer immunotherapy are the key factors driving market growth.

Regional Growth Analysis:

The immuno-oncology assays market is divided into four major regions— North America, Europe, Asia Pacific, and the Rest of the World (RoW).

Asia Pacific is estimated to grow at the highest CAGR during the forecast period. The growing number of CROs in the region, increasing awareness about early detection of cancer, and the shift of manufacturers’ and suppliers’ focus from developed economies to emerging economies are some factors supporting the growth of this region.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=52562166

Key Players:

The key players operating in the global immuno-oncology assays industry are Thermo Fischer Scientific (US), Roche Diagnostics (Switzerland), Agilent Technologies (US), and Illumina (US).

Comments

Popular posts from this blog

Home Healthcare Market - Technological Advancements of Oxygen Therapy Products to Drive the Market

Endoscopy Equipment Market to Reach $35.23 billion - Growing Hospital Investments in Endoscopy Facilities

Interventional Oncology - Emerging Market Growth Factors, Current and Future Perspectives 2024